Archives
-
Pentoxifylline and Preterm Monocyte Hyperinflammation
2026-09-05
The reference study shows that pentoxifylline suppresses LPS-driven inflammatory activation in monocytes from preterm and term infants, while also revealing age-dependent differences in surface-marker regulation and IL-10 production. Its integrated use of flow cytometry, functional phagocytosis testing, and TLR4 mRNA analysis provides a useful framework for interpreting neonatal immune modulation in vitro.
-
Resveratrol Rescues Radiation-Induced Endothelial Injury
2026-09-04
The reference study establishes an in vitro endothelial model for quantifying vascular and DNA damage caused by ionizing radiation. Its central finding is a hormetic, dose-dependent response to resveratrol, with 0.1 μM providing complete functional rescue of radiation-induced DNA damage and tube-formation impairment under the reported conditions.
-
Amplex Red for Reliable H2O2 Assays
2026-09-04
Amplex Red delivers sensitive fluorescence-based hydrogen peroxide and peroxidase measurements across mitochondrial, cellular, and enzyme workflows. Its major practical advantage is paired with a major caveat: carboxylesterase activity can generate resorufin without hydrogen peroxide, so robust assays require matrix-specific controls.
-
Capsazepine for Reliable Cell Assays
2026-09-03
Capsazepine (SKU A3279) offers a defined TRPV1 antagonist framework for troubleshooting variable viability, proliferation, and apoptosis assays. This scenario-based guide covers solvent control, concentration design, off-target interpretation, and practical supplier evaluation for more defensible cell-based experiments.
-
Targeted Tea Polyphenol Nanoparticles for AAA Therapy
2026-09-03
This 2025 ACS Applied Materials & Interfaces study develops cRGD-functionalized tea polyphenol nanoparticles that deliver doxycycline selectively to abdominal aortic aneurysm lesions. The platform combines integrin αvβ3 targeting, ROS-responsive drug release, and intrinsic antioxidant activity to address inflammation, oxidative stress, matrix degradation, apoptosis, and calcification while reducing doxycycline-associated organ toxicity.
-
BIBP 3226 Trifluoroacetate in Cardiac Signaling
2026-09-02
BIBP 3226 trifluoroacetate provides a practical pharmacological entry point for separating NPY Y1 and NPFF signaling in cAMP, neuronal, and cardiac models. This workflow-focused guide connects receptor antagonism with adipose-neural arrhythmia research while emphasizing controls, dosing logic, and troubleshooting.
-
Fenipentol Workflows for GI and CHD Research
2026-09-02
Fenipentol, also called 1-Phenyl-1-pentanol, offers a practical small-molecule entry point for secretory physiology, ESR1-oriented mechanism studies, and tissue-resolved Chuanxiong research. This guide connects formulation, secretion assays, SPME-GC×GC-MS, and troubleshooting into an experimentally cautious workflow.
-
Dye Models for Small Biopsy Detection in Pathology
2026-09-01
The reference study evaluates whether colored dyes can reduce the risk of losing or overlooking 0.2–0.3 cm biopsy fragments during routine surgical pathology processing. Merbromin, hematoxylin, and alcian blue improved tissue visibility, but hematoxylin offered the most favorable balance because pathologists reported less toxicity concern and no interference with routine slide examination.
-
SCH772984 as a Causal Probe of NPC Radioresistance
2026-09-01
SCH772984 is an ERK1/2 inhibitor with a useful profile for testing how MAPK signaling intersects with ferroptosis and radiotherapy resistance. This article translates NPC Ang II–HIF-1α–HILPDA findings into a rigorous, hypothesis-driven assay framework while clearly separating evidence from future applications.
-
USP36–Snail1 Axis in Ribotoxic Stress
2026-08-31
The reference study identifies a JNK–USP36–Snail1 signaling axis that allows solid tumor cells to preserve ribosome biogenesis and survive ribotoxic stress. Its findings explain why homoharringtonine is more effective in leukemia than in solid tumors and support combination strategies that disable this adaptive response.
-
Annexin V-APC/7-AAD Apoptosis Kit Workflow
2026-08-31
Translate drug-induced membrane changes into a rapid, two-parameter readout that separates viable, apoptotic, and membrane-compromised cells. This apoptosis detection kit is especially useful for testing epigenetic therapies such as panobinostat in MLL-rearranged leukemia models while preserving a practical path from plate treatment to flow cytometry or microscopy.
-
PA-824 in Tuberculosis Research: Workflow Guide
2026-08-30
PA-824 combines cell-wall activity with respiratory disruption, making it useful for studying both replicating and non-replicating Mycobacterium tuberculosis. This workflow guide shows how to build concentration-response, time-kill, and combination assays while controlling solvent, stability, and growth-state variables.
-
EGO-Like Complex Controls TOR in Neurospora
2026-08-29
The reference study defines how the VTA–GTR2 EGO-like complex connects amino acid sensing with TORC1 activity and vacuolar localization in Neurospora crassa. Its findings distinguish amino acid-dependent from glucose-dependent TOR regulation and provide a mechanistic framework for studying nutrient control of circadian physiology.
-
BCA Protein Assay Kit for Colitis Research
2026-08-28
Use the BCA Protein Assay Kit to standardize protein concentration measurement across colon tissue, serum, and cell lysates in DSS-colitis workflows. Its 562 nm colorimetric readout supports reproducible normalization for barrier-protein, cytokine, western blot, ELISA, and enzyme-assay studies.
-
Bsa I (RNase-free): Practical DNA Cleavage Guide
2026-08-28
Bsa I (RNase-free), SKU K1095, provides sequence-directed cleavage of DNA containing the 5′—GGTCTC(N)—3′ recognition sequence while minimizing product-associated RNA degradation. It is intended for gene cloning, DNA manipulation, and other molecular biology research workflows, not diagnostic, clinical, or medical use.